Han‐Hsuan Fu
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Reproductive Medicine top 5%
- Co-authors
- Gil MorAyesha B. AlveroIrene VisintinDan‐Arin SilasiMichele K. MontagnaPeter E. SchwartzRui ChenThomas Rutherford
- Topics
- Cancer Research and Treatments (2 papers)Immunotherapy and Immune Responses (2 papers)T-cell and B-cell Immunology (2 papers)
- Journals
- PLoS ONECancerCancer Research
- Partner nations
- United StatesJapan
In The Last Decade
Han‐Hsuan Fu
10 papers receiving 749 citations
Peers
Comparison fields: 5 of 73
- Oncology 413
- Molecular Biology 406
- Cancer Research 237
- Immunology 148
- Reproductive Medicine 122
Countries citing papers authored by Han‐Hsuan Fu
This map shows the geographic impact of Han‐Hsuan Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Hsuan Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Hsuan Fu more than expected).
Fields of papers citing papers by Han‐Hsuan Fu
This network shows the impact of papers produced by Han‐Hsuan Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Hsuan Fu. The network helps show where Han‐Hsuan Fu may publish in the future.
Co-authorship network of co-authors of Han‐Hsuan Fu
This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Hsuan Fu. A scholar is included among the top collaborators of Han‐Hsuan Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Hsuan Fu. Han‐Hsuan Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 21 | |
| 3 | 396 | |
| 4 | 51 | |
| 5 | 16 | |
| 6 | 132 | |
| 7 | 8 | |
| 8 | 22 | |
| 9 | Phenoxodiol, a novel approach for the treatment of ovarian cancer. | 22 |
| 10 | MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer. | 43 |
About Han‐Hsuan Fu
Han‐Hsuan Fu is a scholar working on Biotechnology, Cancer Research and Immunology, having authored 10 papers that have together received 758 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Cancer Research (237 citations), Oncology (413 citations) and Reproductive Medicine (122 citations). Han‐Hsuan Fu has collaborated with scholars based in United States and Japan. Frequent co-authors include Gil Mor, Ayesha B. Alvero, Irene Visintin, Dan‐Arin Silasi, Michele K. Montagna, Peter E. Schwartz, Rui Chen, Thomas Rutherford, Karina Dahl Steffensen and Marianne Waldstrøm. Their work appears in journals such as PLoS ONE, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.